Paige Nickelsen

ORCID: 0000-0003-1448-1071
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sepsis Diagnosis and Treatment
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Hemodynamic Monitoring and Therapy
  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes

University of California, San Diego
2023-2024

UC San Diego Health System
2023-2024

Clopidogrel hyperresponsiveness is a timely topic, with wide ranging reports of hemorrhagic complications, using various clopidogrel dosing strategies following neuroendovascular procedures. This study serves to investigate complications standard doses and timing these in relation the procedure.

10.1177/08971900241273311 article EN Journal of Pharmacy Practice 2024-08-12

Background Vasopressin is recommended as a second-line vasoactive agent for the management of septic shock; however, paucity data to guide its optimal use remains. The aim was evaluate effect time-to vasopressin initiation and norepinephrine (NE) dose at on clinical outcomes in patients presenting with shock. Methods This multi-centered, retrospective, observational study conducted Patients were divided into 2 groups: initiated when NE-equivalent (NEE) < 0.25 mcg/kg/min or ≥ mcg/kg/min....

10.1177/08850666231201364 article EN Journal of Intensive Care Medicine 2023-09-16

Introduction: Vasopressin is recommended as a second-line vasoactive agent for the management of septic shock; however, paucity data to guide its optimal use remains. The aim this study was evaluate effect time-to-vasopressin initiation and norepinephrine (NE) dose at vasopressin on clinical outcomes in patients presenting with shock. Methods: This multi-centered, retrospective, observational conducted Patients were divided into 2 groups: initiated when NE-equivalent (NEE) < 0.25 mcg/kg/min...

10.1097/01.ccm.0001004116.42579.79 article EN Critical Care Medicine 2023-12-14
Coming Soon ...